ONCOLYTIKA LTD
ActiveKey figures
Like most small UK companies, ONCOLYTIKA LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2024/25Sector comparison
SIC 72110Where the company stands among the 3,991 active companies whose first SIC code is 72110 (Research and experimental development on biotechnology).
- BRACCO HORIZONS LIMITED£526.1m
- TAURX THERAPEUTICS MANAGEMENT LTD.£470.3m
- LABCORP EARLY DEVELOPMENT LABORATORIES LIMITED£317m
- JAZZ PHARMACEUTICALS RESEARCH UK LIMITED£289.2m
- GENOME RESEARCH LIMITED£273.7m
- MODERNA BIOTECH UK LIMITED£236.5m
- CURIA (SCOTLAND) LIMITED£183m
- ASTEX THERAPEUTICS LIMITED£163.6m
- HORIZON DISCOVERY GROUP LIMITED£159.6m
- AMGEN LIMITED£134.4m
Positions are approximate. Figures come from each company's latest accounts; money and employee figures are compared only with companies that filed accounts in pounds for a period ending in the last two and a half years and are not dormant, so those groups are smaller than 3,991. The line on each bar marks the median.
Summary: ONCOLYTIKA LTD
What kind of company is it?
ONCOLYTIKA LTD is a private limited company registered with Companies House under company number 07305115. It was incorporated on 6 Jul 2010. Its status is active. The registered office is in Ely (CB6). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).
How is the company doing financially?
The latest accounts in the database are for 2024/25 (period ending 31 Jul 2025); the company files micro-entity accounts. Net assets were £139,950, down 13.5% on the previous year. Total assets were £141,968 and total liabilities £2,590. The company had an average of 2 employees. Figures are available for 6 financial years (2019/20–2024/25).
How does it compare with similar companies?
Compared with 3,991 active companies whose first SIC code is 72110: By net assets it ranks higher than 66% of them (median £20,978). By total assets it ranks higher than 51% of them (median £125,654). By number of employees it ranks higher than 55% of them (median 1). It is older than 89% of them (median age 5.4 years).
Has it received government grants?
It is recorded as the recipient of one central government grant, from Department for Business, Energy and Industrial Strategy.
Who runs and controls the company?
The company has 1 current director. One person with significant control is registered.
When are its next filings due?
The next accounts are due by 30 Apr 2027. The next confirmation statement is due by 7 Jul 2027.
Filed accounts2019/20–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Total assets | 250,064 | 193,374 | 135,412 | 203,463 | 141,968 |
| Total liabilities | 34,525 | 11,434 | 4,156 | 42,233 | 2,590 |
| Net assets / total equity | 215,083 | 181,469 | 131,427 | 161,838 | 139,950 |
| Average number of employees | 2 | 2 | 2 | 2 | 2 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025The principal activity of the company during the year under review was biotechnological research,development and consultancy.
As described in the company's latest filed accounts.
Government grants
1 grantONCOLYTIKA LTD is recorded as the recipient of 1 central government grant.
- AtlasBio - Analytical Technologies for the Lyophilization and Stabilization of BiopharmaceuticalsDepartment for Business, Energy and Industrial Strategy · −£842 · UKRI - Innovate UK - Scheme 22/23
From the Government Grants Register published by the Cabinet Office (financial years 2016/17 onwards, Open Government Licence v3.0). It covers grants from central government departments and their agencies where the register states the recipient's company number and the recipient name matches this company; grants from local authorities, lottery distributors and devolved governments are not included.
History
11 events- Financial year 2024/25 endedAccounts: net assets £140k, 2 employees
- Financial year 2023/24 endedAccounts: net assets £161.8k, 2 employees
- Financial year 2022/23 endedAccounts: net assets £131.4k, 2 employees
- Financial year 2021/22 endedAccounts: net assets £181.5k, 2 employees
- Financial year 2020/21 endedAccounts: net assets £215.1k, 2 employees
- Financial year 2019/20 endedAccounts: net assets £173.8k, 2 employees
- Dr Mark Edward Eccleston registered as a person with significant control
- Barbara KAHAN resignedDirector
Earlier events (3)
- Mark Edward ECCLESTON appointedDirector
- Barbara KAHAN appointedDirector
- Company incorporatedPrivate limited company
Dates as recorded at Companies House: incorporation, name changes, officer appointments and resignations, current persons with significant control, and the end of each financial year with figures in the database. Former persons with significant control are not listed.